Eton Pharmaceuticals
Yahoo Finance • 12 days ago
Why Eton Pharmaceuticals Is Top of the Class Today
Key Points Eton Pharmaceuticals beat on both top and bottom lines last night. Management is licensing a new drug, and raising guidance through the end of 2026.10 stocks we like better than Eton Pharmaceuticals › Eton Pharmaceuticals (NAS... Full story
Yahoo Finance • 13 days ago
Eton Pharmaceuticals jumps on strong Q2 print, 2026 guidance
Shares in Eton Pharmaceuticals (ETON [https://seekingalpha.com/symbol/ETON]) rallied 25% in premarket trading on Friday, driven by a solid quarterly print and 2026 revenue forecast, which the company said would exceed $145M while targeting... Full story
Yahoo Finance • 23 days ago
Eton Pharmaceuticals to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026
DEER PARK, Ill., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today ann... Full story
Yahoo Finance • last month
Apple upgraded, Brinker initiated: Wall Street's top analyst calls
Apple upgraded, Brinker initiated: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by... Full story
Yahoo Finance • 3 months ago
H.C. Wainwright Remains Bullish on Eton Pharmaceuticals’ (ETON) Growth Strategy
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) is one of the best oversold growth stocks to invest in now. H.C. Wainwright lifted the price target on Eton Pharmaceuticals, Inc. (NASDAQ:ETON) to $57 from $52 on May 15, reaffirming a Buy rating on... Full story
Yahoo Finance • 3 months ago
Stock Market Leaders Respect The 21-Day Line. You Should Too.
During stock market uptrends, the 21-day exponential moving average has proved itself to be a strong short-term support for leading stocks. Continue Reading... Full story
Yahoo Finance • 3 months ago
Eton (ETON) Q1 2026 Earnings Call Transcript
Image source: The Motley Fool. Date Thursday, May 14, 2026 at 4:30 p.m. ET Call participants Chief Executive Officer — Sean Brynjelsen Chief Financial Officer — James Gruber Chief Commercial Officer — Ipek Erdogan-Trinkaus Executive Vi... Full story
Yahoo Finance • 3 months ago
Eton projects revenue to exceed $120M in 2026 as it targets a 50% adjusted EBITDA margin by 2028
Earnings Call Insights: Eton Pharmaceuticals (ETON) Q1 2026 MANAGEMENT VIEW * "The first quarter was another great quarter for Eton. We achieved record product sales delivering 73% year-over-year product revenue growth. We launched 2 n... Full story
Yahoo Finance • 4 months ago
Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700
DEER PARK, Ill., April 27, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today an... Full story
Yahoo Finance • 4 months ago
Eton Pharmaceuticals Names Judith Matthews CFO, Effective June 1
(RTTNews) - Eton Pharmaceuticals Inc. (ETON) on Thursday said it has appointed Judith M. Matthews as Executive Vice President, Accounting and Finance, effective immediately. Matthews will assume the role of Chief Financial Officer on June... Full story
Yahoo Finance • 6 months ago
Investment Manager Fully Exits Immunome Stock in $37.3 Million Sale, According to Latest SEC Filing
On February 17, 2026, Opaleye Management Inc. reported selling out its entire stake in Immunome(NASDAQ:IMNM), an estimated $37.30 million trade based on quarterly average pricing. What Happened According to its SEC filing dated February... Full story
Yahoo Finance • 6 months ago
Investment Manager Sells $5.1 Million Worth of LQDA Stock, According to Recent SEC Filing
Opaleye Management Inc. disclosed in a February 17, 2026, SEC filing that it sold 180,000 shares of Liquidia(NASDAQ:LQDA), an estimated $5.12 million trade based on quarterly average pricing. What Happened According to a SEC filing dated... Full story
Yahoo Finance • 6 months ago
Eton Pharma Acquires U.S. Commercialization Rights For Hemangeol In Infantile Hemangioma
(RTTNews) - Eton Pharmaceuticals, Inc. (ETON), a commercial-stage pharmaceutical company, Wednesday announced in-licensing of U.S. commercialisation rights to Hemangeo oral solution from Pierre Fabre Medicament SAS, indicated for the treat... Full story
Yahoo Finance • 6 months ago
Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution
DESMODA is the first and only FDA-approved desmopressin oral solutionCommercial launch expected on March 9thDESMODA eliminates tablet splitting and crushing, enabling precise, individualized dosing for patients of all agesThe product is ex... Full story
Yahoo Finance • 6 months ago
Catalyst Watch: Nvidia blockbuster, JPMorgan event, and reactions to the tariff reset
[New York City and London multiple exposure image] Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. MONDAY... Full story
Yahoo Finance • 8 months ago
Highlighting December 2025's Growth Leaders With Insider Ownership
As the United States stock market grapples with concerns over an AI bubble, technology shares have been under pressure, causing declines in major indices like the Nasdaq and Dow Jones Industrial Average. In such a volatile environment, com... Full story
Yahoo Finance • 9 months ago
Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th
DEER PARK, Ill., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today ann... Full story
Yahoo Finance • 9 months ago
Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th
DEER PARK, Ill., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today ann... Full story
Yahoo Finance • 10 months ago
Eton Pharma (ETON) Q3 2025 Earnings Transcript
Image source: The Motley Fool. DATE Thursday, November 6, 2025 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Sean BrynjelsenChief Financial Officer — James GruberExecutive Vice President, Corporate Development — David Kre... Full story
Yahoo Finance • 10 months ago
Eton outlines fivefold INCRELEX market opportunity and targets $50M peak adrenal franchise sales amid record Q3 growth
Earnings Call Insights: Eton Pharmaceuticals (ETON) Q3 2025 MANAGEMENT VIEW * Sean Brynjelsen, President, CEO & Director, announced "another record quarter for the company with triple-digit year-over-year revenue growth" and highlighte... Full story